Latest Macular edema Stories
TARRYTOWN, N.Y., Jan. 23, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
ATLANTA, Jan. 14, 2015 /PRNewswire/ -- Alimera Sciences, Inc.
ATLANTA, Dec. 1, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
TARRYTOWN, N.Y., Nov. 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
ATLANTA, Nov. 17, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
New research from Kantar Health’s National Health and Wellness Survey shows European patients with macular edema are more likely to use insulin and have been diagnosed longer. New
TARRYTOWN, N.Y., Oct. 17, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Findings help product development at Diopsys, Inc. Pine Brook, NJ (PRWEB) October 10, 2014 Research scientists from the University of Alabama, Birmingham
- The word or words serving to define another word or expression, as in a dictionary entry.